Genky Drugstores Co., Ltd. · TSE:9267

Genky Drugstores — Q1 FY2027 Earnings Presentation

16 slides from Genky Drugstores's earnings presentation, Oct 30, 2026

  1. Slide 1: FY2027 1Q Financial Results

    FY2027 1Q Financial Results Genky DrugStores Co., Ltd. (Code number: 9267, TSE Prime) 2026.10

  2. Slide 2: blank page

    blank page

  3. Slide 3: FY2027 1Q Accounting period (YoY change)

    FY2027, 1Q Accounting period (YoY change) Net Sales Net sales came in ¥290 million below plan, mainly due to a sharp decline in rice prices and sluggish sales of seasonal merchandise caused by lower-than-usual temperatures. Store openings and closures proceeded as planned. Gross The gross profit mar

  4. Slide 4: 1Q Sales Summary: Monthly Net Sales YoY Change

    Monthly Net sales YoY Change (existing stores) (1Q Sales Summary) Existing-store sales were 1.0pt below plan, due to a sharp drop in rice prices and weak seasonal sales amid cool weather. Solid new-store performance limited the shortfall in total sales to 0.5pt. Lower rice prices pushed both average

  5. Slide 5: Gross margin and SG&A ratio of drugstore companies

    Gross margin and SG&A Ratio of Drugstore companies (Quarterly trends) Gross margin SG&A ratio 36% 36% COVID-19 pandemic 34% 34% 32% 32% 30% 30% 28% 28% 26% 26% 24% 24% 22% 22% 20% 20% 18% 18% 16% 16% COVID-19 pandemic 14% 14% Co Ya Ao Su Tu Wa Ma Genky 5

  6. Slide 6: Operating margin of drugstore companies

    Operating margin of Drugstore companies (Quarterly trends) 9% Operating margin 8% 7% 6% 5% 4% 3% 2% 1% COVID-19 pandemic 0% FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026 FY2027 Co Ya Ao Su Tu We Ma Genky 6

  7. Slide 7: Financial Results (Quarterly trends)

    Financial Results (Quarterly trends) 25% 65,000 7,000 Net sales(left axis) Operating profit(right axis) 10.0% 60,000 6,000 20% 55,000 5,000 15% 50,000 4,000 45,000 10% 5.0% 3,000 40,000 Gross margin(left axis) 2,000 5% 35,000 SG&A ratio(left axis) Operating margin(right axis) 30,000 1,000 0% 0.0% 25

  8. Slide 8: KPI (Quarterly and Full-year trends)

    KPI (Quarterly and Full-year trends) While maintaining “SG&A per TSUBO*” at 200,000 yen, the EDLP strategy will increase “Sales per TSUBO” (“Gross profit per TSUBO” will also increase), thereby improving “Operating profit per TSUBO”. *TSUBO is a unit of area, about 3.3㎡ FY2027 Items Unit FY2022 FY20

  9. Slide 9: FY2027 Forecasts (Previously Presented)

    FY2027 Forecasts (Previously Presented) FY2026 FY2027 YoY change Results forecasts changes in million yen margin million yen margin margin (ratio) +23,361 ※SSS Net sales 220,638 - 244,000 - +10.6% +3.5% +4,976 Gross profit 44,923 20.4% 49,900 20.5% +0.1pt +11.1% +3,962 SG&A 33,938 15.4% 37,900 15.5%

  10. Slide 10: Financial Results and Forecasts (Previously Presented)

    Financial Results and Forecasts (Previously Presented) (Millions of Yen) FY2027 FY2022 FY2023 FY2024 FY2025 FY2026 (Forecasts) Store opening 43 30 31 54 57 75 Store closing 0 7 7 7 3 5 Renovation 21 3 3 1 8 9 (Large→Regular) - Logistics Center - 1 - - 1 One more building planned for FY2029 Net sales

  11. Slide 11: Cash Flow Control (Previously Presented)

    Cash Flow Control (Previously Presented) 95% of investing cash flow is directed to growth investments in new stores and new distribution centers, which have driven EPS growth.We will maintain a proactive stance of investing at least 1.0x operating cash flow, and continue leveraged growth investment

  12. Slide 12: ROE, Equity Ratio and Cost of Equity (Previously Presented)

    ROE, Equity Ratio and Cost of Equity (Previously Presented) Through continuous, leveraged growth investment, we manage ROE at around 13%, sustaining investment efficiency well above our cost of equity (Note).We regard an equity ratio of approx. 30%–40% as an appropriate balance, and will continue to

  13. Slide 13: Sustaining EPS Growth of 10% or More (Previously Presented)

    Sustaining EPS Growth of 10% or More (3FY avg.) (Previously Presented) EPS has grown at a CAGR of 12.8% over the past 10 years, which we believe reflects customer support for our business model. We will continue to achieve EPS growth of 10% or more on a 3-year average basis by serving local customer

  14. Slide 14: blank page

    blank page

  15. Slide 15: blank page

    blank page

  16. Slide 16: Contact Information

    -Note- The forecast figures in this presentation are based on information currently available to the Company and assumptions based on uncertain factors that may affect future performance. In addition, the explanations given in this presentation contain forward looking statements, judgments, plans or

Genky DrugStores — Q1 FY2027 Earnings Presentation on 6ix